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We investigated the inhibitory eﬀects of hydroquinone on cytokine release, phagocytosis, NO production, ROS generation,
cell-cell/cell ﬁbronectin adhesion, and lymphocyte proliferation. We found that hydroquinone suppressed the production of
proinﬂammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6], secretion of toxic molecules [nitric
oxide (NO) and reactive oxygen species (ROS)], phagocytic uptake of FITC-labeled dextran, upregulation of costimulatory
molecules, U937 cell-cell adhesion induced by CD18 and CD29, and the proliferation of lymphocytes from the bone marrow
and spleen. Considering that (1) environmental chemical stressors reduce the immune response of chronic cigarette smokers
and children against bacterial and viral infections and that (2) workers in petroleum factories are at higher risk for cancer, our
data suggest that hydroquinone might pathologically inhibit inﬂammatory responses mediated by monocytes, macrophages, and
lymphocytes.
Copyright © 2008 Jae Youl Cho.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Monocytes, macrophages, and lymphocytes are the major
types of cells that mediate innate and adaptive immunity.
Upon stimulation by bacterial, fungal, or viral infections,
macrophages at the infection site release many diﬀerent
proinﬂammatory cytokines [e.g., tumor necrosis factor
(TNF)-α and interleukin (IL)-1] and cytotoxic and inﬂam-
matory molecules [e.g., nitric oxide (NO) and oxygen
species intermediates (ROS)] via the activation of the pat-
tern recognition receptor (PRR). Monocytes continuously
migrate to the inﬂamed site via increased adhesion events
mediated by interactions with adhesion molecules such as
selectins and integrins. The migrating monocytes eventually
diﬀerentiate into macrophages for activation and further
mediation of inﬂammatory responses. Macrophages that
have been fully activated by bacterial or fungal cell products
such as LPS, peptidoglycan (PEG), or β-glucan upregulate
surface expression of costimulatory molecules such as CD80,
CD86, and major histocompatibility molecule class II in
order to enhance T cell proliferation. Activated T cells also
diﬀerentiateintoTh1orTh2cellstomodulateBcellfunction
for antibody production.
Recent decades have seen increased prevalence of several
immunopathological diseases including cancers, allergic dis-
eases such as eczema and atopic dermatitis, and respiratory
tract infections in chronic cigarette smokers and children
[1]. It is thought that multiple environmental and genetic
factors, in addition to smoking, are the main reasons for
these phenomena. Numerous chemically toxic molecules are
particularly known to have pathological eﬀects. Benzene is
known to be a human carcinogen [2]. Even though it is
chemically hazardous, occupational and habitual exposure
to benzene still occurs in the petrochemical and petroleum
reﬁningindustryaswellasthroughsomefoodssuchascoﬀee
[3].
Hydroquinone (benzene-1,4-diol) (Figure 1)i sam a j o r
component of cigarette smoke and coﬀee, and a metabolite
of benzene via a cytochrome p450-mediated pathway. It
is also a heavily used industrial chemical, a petroleum2 Mediators of Inﬂammation
by-product, and an ubiquitous environmental pollutant.
Evidence suggesting that cigarette smoking is allergenic and
that benzene metabolites are strong haptens [4] stimulated
our interest in hydroquinone as an immunotoxicological
agent in allergic diseases. Previous reports have suggested
that hydroquinone enhances Th2 response-mediated allergic
diseases via blockade of interferon (IFN)-γ production in
Th1 cells, enhanced interleukin-4 production in CD4+ T
cells, increased immunoglobulin E levels in antigen-primed
mice, and blockade of IL-12 production via suppression of
nuclear factor (NF)-κB binding activity [5]. In addition,
hydroquinone-mediated inhibition of the production of
several cytokines and toxic molecules such as IL-1β,I L - 2 ,
and NO [6–8] suggests that benzene metabolites might
interrupt global immune responses in addition to inducing
allergic disease. To date, the pathological importance and
mechanisms of benzene metabolites in the modulation of
immune responses remain unclear. In the present study,
we, therefore, investigated the eﬀect of hydroquinone, a
representative reactive benzene metabolite, on the modu-
lation of inﬂammatory processes mediated by monocytes,
macrophages, and lymphocytes.
2. MATERIALS AND METHODS
2.1. Materials
L-cysteine, phorbol 12-myristate 13-acetate (PMA), cur-
cumin, 1,4-dithiothreitol (DTT), α-tocopherol, dihydrorho-
damine 123 (DHR123), peptidoglycan (PGN), zymosan,
lipopolysaccharide (LPS), α-tocopherol, sodium nitroprus-
side(SNP),concanavalin(Con)A,ﬂuoresceinisothiocyanate
(FITC)-label dextran, and hydroquinone were obtained
from Sigma Chemical Co. (St. Louis, Mo, USA). BAY 11-
7082 (BAY) was from Calbiochem (La Jolla, Calif, USA).
RAW264.7 and U937 cells were purchased from ATCC
(Rockville, Md, USA). All other chemicals were of reagent
grade. Aggregation-inducing antibody against CD29 (MEM
101A, puriﬁed IgG1) wasused asreported previously[9–11].
FITC-labeled antibodies to CD80, CD86, CD29, and CD18
were obtained from Immunotech (Marseilles, France).
2.2. Animals
C57BL/6 male mice (6–8 weeks old, 17–21g) were obtained
from DAEHAN BIOLINK (Chungbuk, Korea). The mice
were maintained in plastic cages under conventional condi-
tions. Water and pelleted diets (Samyang, Daejeon, Korea)
were supplied ad libitum. Studies were performed in accor-
dance with guidelines established by the Kangwon University
Institutional Animal Care and Use Committee.
2.3. Preparationofperitonealmacrophages
Peritoneal exudates were obtained from C57BL/6 male
mice (7-8 weeks old, 17–21g) by lavage four days after
intraperitoneal injection of 1mL sterile 4% thioglycollate
broth (Difco Laboratories, Detroit, Mich, USA). Cells were
washed and resuspended in RPMI 1640 containing 2% FBS
OH
OH
Figure 1: Chemical structure of hydroquinone.
and plated in 100mm tissues culture dishes for 4 hours at
37
◦Ci na5 %C O 2 humidiﬁed atmosphere.
2.4. Cellculture
RAW 264.7 and U937 cells obtained from American Type
Culture Collection (Rockville, Md, USA) were cultured with
RPMI medium supplemented with 10% heat-inactivated
fetal bovine serum (Gibco, Grand Island, NY, USA), glu-
tamine,andantibiotics(penicillinandstreptomycin)at37
◦C
with 5% CO2.
2.5. Cytokineproduction
The inhibitory eﬀect of hydroquinone on TNF-α production
was determined as previously described [12]. Hydroquinone
was solubilized with vehicle (100% ethanol) and diluted
with RPMI1640. RAW264.7 cells (2 × 106 cells/mL) were
incubatedwithLPS(2.5μg/mL)inthepresenceorabsenceof
hydroquinone for 6 hours. Supernatants were assayed for the
levelsofTNF-α,IL -1β,andIL-6usingamouseTNF-αELISA
kit (Amersham, Little Chalfont, Buckinghamshire, UK).
2.6. NOassay
RAW 264.7 cells were preincubated with or without tested
compounds (hydroquinone and L-NAME) for 30 minutes
and continuously activated with LPS (2.5μg/mL) for 24
hours. Nitrite determination was carried out using Griess
reagent [13]. The absorbance of the product dye was mea-
sured at 540 nm using a ﬂow-through spectrophotometer.
2.7. MTTassay
Cell proliferation was measured by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, as
described previously [12].
2.8. ExtractionoftotalRNAandsemiquantitative
RT-PCRampliﬁcation
The total RNA from LPS-treated RAW264.7 cells was
prepared by adding TRIzol reagent (Gibco BRL), accord-
ing to the manufacturer’s protocol. Semiquantitative RT
reactions were conducted using MuLV reverse transcriptase
as reported previously [14]. Primers (Table 1)( B i o n e e r ,
Daejeon, Korea) were used as previously reported [15].Jae Youl Cho 3
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Figure2:EﬀectofhydroquinoneontheproductionofcytokinesandtheirmRNAexpressioninLPS-activatedRAW264.7cells.(a)RAW264.7
cells (2 × 106 cells/mL) were incubated with indicated concentrations of HQ (hydroquinone) in the presence or absence of LPS (2μg/mL)
for 12 hours. Secreted levels of TNF-α,I L - 1 β, and IL-6 in culture supernatant were determined by ELISA. (b) The mRNA levels of
proinﬂammatory cytokines from the RAW264.7 cells were determined by semiquantitative RT-PCR. The results show one representative
experiment of three. ∗p<. 05 and ∗∗p<. 01 represent signiﬁcant diﬀerence as compared to control.
Table 1 :P r i m e r su s e df o rR T - P C Ra n a l y s i s( F :f o rw a r d ,R :r e v e r s e ) .
Gene Primer sequences
TNF-α F5  -TTGACCTCAGCGCTGAGTTG-3 
R5  -CCTGTAGCCCACGTCGTAGC-3 
IL-1β F5  -CAGGATGAGGACATGAGCACC-3 
R5  -CTCTGCAGACTCAAACTCCAC-3 
IL-6 F5  -GTACTCCAGAAGACCAGAGG-3 
R5  -TGCTGGTGACAACCACGGCC-3 
iNOS F5  -CCCTTCCGAAGTTTCTGGCAGCAGC-3 
R5  -GGCTGTCAGAGCCTCGTGGCTTTGG-3 
GAPDH F5  -CACTCACGGCAAATTCAACGGCAC-3 
R5  -GACTCCACGACATACTCAGCAC-3 
2.9. ROSdetermination
The level of intracellular ROS was determined by the change
in ﬂuorescence resulting from oxidation of the ﬂuorescent
probeDHR123[16].Brieﬂy,5×105 cells/wellwereincubated
with hydroquinone for 30 minutes and then with SNP
(125μM) for an additional 6 hours. After a ﬁnal incubation
with 2.5μM DHR123 for 1 hour, the intracellular ROS level
was determined using ﬂow cytometry.
2.10. Phagocyticuptake
To measure the phagocytic activity of RAW264.7 cells, a
previously reported method was used with slight modi-
ﬁcations [17]. RAW 264.7 cells (1 × 106 cells/mL) were
preincubated with or without hydroquinone for 30 minutes,
and further incubated for 6 hours. Finally, the cells were
further incubated with FITC-dextran (1mg/mL) for 30
minutes at 37
◦C. The incubation was stopped by addition of
2mL of ice-cold PBS, and the cells were washed four times
with cold PBS. After ﬁxing the cells with 3.7% formaldehyde,
phagocytic uptake was analyzed using a FACScan device
(Becton Dickinson, San Jose, Calif, USA).
2.11. Cell-cellorcell-extracellularmatrixprotein
(ﬁbronectin)adhesionassay
U937 cell adhesion assay was performed as previously
reported [9, 18]. Brieﬂy, U937 cells maintained in com-
plete RPMI1640 medium (supplemented with 100U/mL of
penicillin and 100μg/mL of streptomycin, and 10% FBS)
were preincubated with hydroquinone for 1 hour at 37
◦C
and further incubated with activating (agonistic) antibodies
(1μg/mL) in a 96-well plate. After a 3-hour incubation, cell-
cellclustersweredeterminedbyhomotypiccell-celladhesion
assay using a hemocytometer [18] and analyzed with an
inverted light microscope equipped with a COHU high-
performance CCD (Diavert) video camera. For the cell-
ﬁbronectin adhesion assay, hydroquinone-treated U937 cells
(5×105 cells/well) were seeded on a ﬁbronectin (50μg/mL)-
coated plate and incubated for 3 hours [19]. After removal
of unbound cells with PBS, attached cells were treated with
0.1% crystal violet for 15 minutes. The OD value at 540 nm
was measured by a Spectramax 250 microplate reader.
2.12. Flowcytometricanalysis
Surface levels of CD80, CD86, CD29, and CD18 on U937 or
RAW264.7 cells were determined by ﬂow cytometric analysis
as reported previously [18]. Stained cells were analyzed on a
FACScan device (Becton Dickinson, San Jose, Calif, USA).4 Mediators of Inﬂammation
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Figure 3: Eﬀects of hydroquinone on the production of NO in LPS-treated RAW 264.7 cells or peritoneal macrophages. (a) and (b)
RAW264.7 cells or peritoneal macrophages (1 × 106) were pretreated with various concentrations of HQ (hydroquinone) in the presence
or absence of LPS (2μg/mL), PGN (10μg/mL), or zymosan (400μg/mL) for 24 hours. The level of NO was determined by Griess reagent
as described in Section 2. (c) The mRNA levels of proinﬂammatory cytokines from RAW264.7 cells were determined by semiquantitative
RT-PCR. The results show one representative experiment of three. ∗p<. 05 and ∗∗p<. 01 represent signiﬁcant diﬀerence as compared to
control.
2.13. Preparationoflymphocytesfrombonemarrow
andspleenandtheirproliferationassay
Splenocytes or bone marrow-derived cells (5×105 cells/well)
were prepared from the spleens or bone marrow of mice
killed by cervical dislocation under sterile conditions,
as described previously [12]. Brieﬂy, the splenocytes
or bone marrow-derived cells were released by teasing
them into RPMI-1640 medium supplemented with
20mM N-[2-hydroxyethyl]piperazine-N
 -[2-ethanesulfonic
acid](HEPES) buﬀer. The splenocytes or bone marrow-
derivedcells(5×106 cells/mL)wereculturedin96-wellplates
in the presence and absence of T or B lymphocyte mitogens
(concanavalin A (Con A) and LPS) with hydroquinone in a
total volume of 200μL/well under the same conditions for
48 hours. Proliferation was determined by MTT assay.
2.14. Statisticanalysis
Student’st-testandone-wayANOVAwereusedtodetermine
the statistical signiﬁcance between experimental and control
groups. P values of 0.05 or less were considered to be
statistically signiﬁcant.
3. RESULTS
3.1. Effectofhydroquinoneonmacrophageactivation
Previously, we reported that hydroquinone strongly dimin-
ishes LPS-induced TNF-α production with an IC50 value
of 14.8μM. In this study, we examined its inhibitory eﬀect
on other inﬂammatory cytokines including IL-1β and IL-6.
Figure 2(a) shows that hydroquinone suppressed production
of cytokines without altering cell viability (data not shown).
The inhibition of these cytokines also appeared at the
transcriptional level (Figure 2(b)), as we had previously
shown for TNF-α production.
Since we had also previously reported that hydro-
quinone could modulate NO production, we next charac-
terized hydroquinone inhibition of NO production under
various stimulation conditions. Figure 3(a) shows thatJae Youl Cho 5
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Figure 4: Eﬀects of hydroquinone on ROS generation in SNP-induced RAW 264.7 cells. (a) Antioxidant eﬀect of hydroquinone was
examined by DPPH assay as described in Section 2. (b) RAW264.7 cells (1 × 106) were pretreated with various concentrations of HQ
(hydroquinone) in the presence or absence of SNP (100μM) for 30 minutes. The level of generated ROS was determined by ﬂowcytometric
analysis as described in Section 2 . ∗p<. 05 and ∗∗p<. 01 represent signiﬁcant diﬀerence as compared to control.
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Figure 5: Eﬀect of hydroquinone on the phagocytic uptake of FITC-labeled dextran. RAW264.7 cells (1 × 106) were incubated with in the
indicated concentrations of HQ (hydroquinone) in the presence or absence of 1 mg/mL of FITC-labeled dextran for 30 minutes. The uptake
of dextran was detected by ﬂow cytometric analysis as described in Section 2. ∗∗p<. 01 represents signiﬁcant diﬀerence as compared to
control.
hydroquinone inhibited zymosan-induced NO production,
whereas LPS-induced NO production was only weakly
blocked, suggesting that dectin-1 and TLR2-mediated NO
production pathways might be more sensitive targets of
hydroquinone. Furthermore, hydroquinone-mediated inhi-
bition of peritoneal macrophage-mediated NO produc-
tion was also observed (Figure 3(b)). Thus, hydroquinone
(as well as the PI3K inhibitors LY294002 and wortman-
nin) concentration-dependently suppressed NO production
in LPS-treated macrophages, whereas the antioxidant α-
tocopherol did not aﬀect NO production, even under
eﬀective antioxidative conditions. Moreover, hydroquinone
alsodiminished LPS-inducediNOS expression (Figure 3(c)),
as reported previously [8].6 Mediators of Inﬂammation
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Figure 6: Eﬀect of hydroquinone on surface expression of costimu-
latorymolecules.(a)and(b)RAW264.7orU937cells(1×106)w e r e
incubated with indicated concentrations of HQ (hydroquinone) in
the presence or absence of LPS (2μg/mL) for 24 hours. The surface
expression of CD80 and CD86 was determined by ﬂow cytometric
analysis as described in Section 2. ∗∗p<. 01 represents signiﬁcant
diﬀerence as compared to control.
ROS generation is an important event in inﬂammatory
responses. We, therefore, examined the ROS scavenging
activity of hydroquinone. As reported previously, hydro-
quinone eﬀectively scavenged radical activity as determined
by DPPH assay (Figure 4(a)). Furthermore, this compound
alsoneutralizedradicalgenerationinSNP-treatedRAW264.7
cells, as was the case for α-tocopherol (Figure 4(b)).
Since phagocytosis is representative of inﬂammatory
responses, the eﬀects of hydroquinone on phagocytic uptake
RAW264.7 cells Vehicle HQ (25μM)
Normal
PMA
(10ng/mL)
Figure 7: Eﬀect of hydroquinone on PMA-induced morphological
changes. RAW264.7 cells (1 × 105) were incubated with indicated
concentrations of HQ (hydroquinone) in the presence or absence
of PMA (10 ng/mL) for 72 hours. The images of the cells in culture
wereobtainedusinganinvertedphasecontrastmicroscopeattached
to a video camera.
of FITC-dextran were investigated. Figure 5 shows that
hydroquinone concentration-dependently suppressed dex-
tranuptake,suggestingthatitcouldblocktheinitialresponse
of macrophage activation. Figure 6 shows that hydroquinone
and BAY 11-7082 suppressed the upregulation of CD80
and CD86 by LPS-induced dextran uptake. However, hydro-
quinonedidnotblocknormalexpressionofCD80andCD86
and rather enhanced it in both RAW264.7 (Figure 6(a)) and
U937 cells (Figure 6(b)).
Figure 7 shows that 25μM hydroquinone failed to sup-
press morphological changes of RAW264.7 cells induced
by PMA-mediated actin cytoskeleton rearrangement. These
data suggest that the pharmacological eﬀects of hydro-
quinone might occur in a signal-dependent manner.
3.2. Effectofhydroquinoneonthecell
adhesionofmonocytes
Since we previously reported the eﬀects of hydroquinone on
CD29-mediated cell-cell adhesion, in this study we evalu-
ated ﬁbronectin-cell adhesion and CD18-mediated cell-cell
aggregation.Figures8(a)and8(b)showthatCD18-mediated
cell-cell adhesion induced by PMA and CD29-mediated
cell-cell adhesion was strongly suppressed by hydroquinone
treatment. In contrast, hydroquinone did not block cell-
ﬁbronectin adhesion events (Figure 8(c)), indicating that
hydroquinone might speciﬁcally modulate cell-cell adhesion
events and not cell-matrix adhesion. Because these adhesion
models are known to depend on CD29 and CD18, the
eﬀects of hydroquinone on surface expression of these
adhesion molecules were additionally examined. Figure 8(d)
shows that hydroquinone treatment signiﬁcantly diminished
surface levels of CD29 and CD18; such downregulation
might comprise an inhibitory mechanism for monocyte
adhesion.Jae Youl Cho 7
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Figure 8: Eﬀect of hydroquinone on cell-cell or cell-ﬁbronectin adhesion events and surface levels of integrins (CD18 and CD29). (a) and
(b) U937 cells (1×106) were incubated with indicated concentrations of HQ (hydroquinone) in the presence or absence of a proaggregation
(activating) antibody against CD29 (MEM101A (1 μg/mL)) for 2 hours. The extent of cell-cell aggregation was determined by quantitative
cell-cell adhesion assay as described in Materials and Methods. (b) Images of cells in culture were obtained using an inverted phase contrast
microscope attached to a video camera. (c) U937 cells pretreated with hydroquinone were seeded on ﬁbronectin (50μg/mL)-coated plates
and further incubated for 3 hours. Attached cells were determined by crystal violet assay, as described in Section 2. (d) U937 cells were
incubated with hydroquinone (12.5μM) for 3 hours. The surface expression of adhesion molecules (CD18 and CD29) was determined by
ﬂow cytometric analysis as described in Section 2. ∗∗p<. 01 represents signiﬁcant diﬀerence as compared to control.
3.3. Effectofhydroquinoneontheproliferationof
lymphocytesfrombonemarroworspleen
Lymphocyte proliferation is important for prolonged
immune responses. Therefore, we determined whether
hydroquinone could modulate lymphocyte proliferation
induced by the T cell mitogen Con A or the B cell mitogen
LPS. Figure 9(a) shows that hydroquinone concentration-
dependently suppressed the normal viability of splenocytes
and bone marrow-derived cells. Figure 9(b) shows, however,
that T cell and B cell responses to hydroquinone varied
according to tissue origin. LPS-induced B cell proliferation
from bone marrow-derived cells was not blocked by 25μM
hydroquinone, whereas Con A-induced T cell proliferation8 Mediators of Inﬂammation
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Figure 9: Eﬀect of hydroquinone on the viablility or proliferation of splenic and bone marrow-derived lymphocytes induced by Con
A and LPS. (a) Splenic lymphocytes (5 × 106 cells/mL) were incubated with hydroquinone under normal culture conditions. (b) Bone
marrow-derived lymphocytes (5×106 cells/mL) were incubated with hydroquinone in the presence or absence of Con A (1μg/mL) and LPS
(10μg/mL).CellviabilityorproliferationwasdeterminedbyMTTassay. ∗p<. 05and ∗∗p<. 01representsigniﬁcantdiﬀerenceascompared
to normal or control.
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Figure 10: Eﬀect of thiol-containing compounds on hydroquione-
mediated inhibition of NO production and lymphocyte prolifera-
tion. (a) RAW264.7 cells (1 × 106) were pretreated with L-cysteine
(800μM) or DTT (100μM) and HQ (hydroquinone, 25μM) in
the presence or absence of LPS (2.5μg/mL) for 24 hours. The
level of NO was determined by Griess reagent as described in
Section 2. (b) Bone marrow-derived cells were incubated with L-
cysteine (800μM) or DTT (100μM) and hydroquinone (25μM) in
the presence or absence of Con A (1μg/mL) for 24 hours. ∗∗p<
.01 and ##p<. 01 represent signiﬁcant diﬀerence as compared to
control or HQ-treated group.
was greatlysuppressed. Incontrast, Con A- and LPS-induced
proliferation of T and B cells from splenocytes showed
similar levels of inhibition, suggesting that sensitivity of
lymphocytes to hydroquinone might be tissue dependent.
3.4. Effectofthiol-containingcompoundson
hydroquinone-mediatedinhibition
Finally, the importance of thiolation by hydroquinone was
explored using NO production and bone marrow cell pro-
liferation. Interestingly, two thiol-containing compounds, L-
cysteine, and DTT abolished the inhibitory eﬀects of hydro-
quinone on NO production and T cell proliferation from
bone marrow-derived cells (Figure 10). These results suggest
that hydroquinone inhibition might require thiolation of
intracellular target proteins.
4. DISCUSSION
In this study, we explored the eﬀect of hydroquinone on in-
ﬂammatory responses mediated by monocytes, macro-
phages, and lymphocytes. Our results suggest that hydro-
quinone can strongly suppress cellular responses required
for inﬂammation, including cytokine production (Figure 2),
NO generation (Figure 3), ROS release (Figure 4), phago-
cytic uptake (Figure 5), surface expression of costim-
ulatory molecules (Figure 6), U937 cell-cell adhesion medi-
ated by CD29 and CD18 (Figure 8), and the proliferation
of lymphocytes isolated from bone marrow and spleen
(Figure 9).
The molecular mechanism of hydroquinone-mediated
downregulation of cellular inﬂammatory responses is not
yet fully understood. Recently, we and others have reported
that hydroquinone can reduce the DNA binding of NF-κB
[5, 20] and block the phosphorylation of Akt [8]. Although
hydroquinone has been reported as a good NF-κB inhibitor,
severallinesofevidencesupportthatitmightblockupstreamJae Youl Cho 9
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Figure 11: Schematic diagram of hydroquinone-mediated inhibition.
signaling of either NF-κB activation or innate and adaptive
immune responses. In the present study, the maximum
anti-TNF-α eﬀect of hydroquinone was observed when
treatment occurred before LPS administration; this suggests
that early signaling events occurring within 30 minutes
might be potential hydroquinone targets [8]. Additionally,
hydroquinone treatment still blocked NF-κB-independent
cellular responses such as integrin-mediated cell adhesion
[21] and phagocytic uptake (Figure 5). Since the activa-
tion of PI3K/Akt, but not MAPKs, is necessary for these
inﬂammation-related cellular events as well as for activation
of NF-κB[ 22], it is possible that hydroquinone might inhibit
PI3K/Akt. This is supported by a previous study in which
hydroquinone diminished the phosphorylation of Akt, and
where the PI3K inhibitors LY294002 and wortmannin dis-
playedbroadspectruminhibitionofinﬂammatoryresponses
[8] similar to that observed for hydroquinone in the present
study.
Recently, hydroquinone has been reported to be a potent
antioxidant with radical scavenging activities [6, 23], and
to induce hemeoxygenase-1 expression. [8] similarly to
most antioxidants. However, we unexpectedly found that
hydroquinone itself was able to enhance radical generation
in RAW264.7 cells to similar extent as LPS [8], suggesting a
role as a strong pro-oxidant agent with chemical reactivity
[24]. Interestingly, we found that hydroquinone reacts with
sulfhydryl groups of thiol compounds, such as L-cysteine,
DTT, and N-acetyl-L-cysteine (Figure 10). This chemical
reactivity appears to depend on the position of hydroxyl
groups in the benzene backbone. Hydroxyl groups in the
para position were conﬁrmed to be the most reactive,
since catechol with ortho groups and resorcinol with meta
groups showed reduced inhibitory eﬀects [25]. Similar
modes of action were reported for sesquiterpene lactone
compounds with reactive α-butyro-γ-lactone rings, where
these involved the direct binding of NF-κBt oD N A v i a
direct thiolation of 165-cysteine residue of the p65 NF-κB
subunit [12, 26]. The eﬀects of hydroquinone may thus
occur as the result of direct binding to L-cysteine residues
critically involved in the activity of target proteins such as
PI3K/Akt.
We and other groups have proposed that hydroquinone
could have potential curative eﬀects in inﬂammatory disease
[6, 8, 25]. Nonetheless, environmental toxicity is an impor-
tant consideration since hydroquinone is topically applied
for skin whitening. Because of its potential cancer risk,
some countries (e.g., France) have banned the use of this
compound. The possible adverse eﬀects are thought to arise
from its reactivity, as it is considered the most potent DNA-
damagingbenzenemetabolite.Furthermore,thereactivityof
hydroquinone is known to be increased in the presence of
NO [27].
Hydroquinone is also a major component of cigarette
smoke and may cause increased rates of higher respiratory
tract infection in chronic cigarette smokers [28, 29]. Our
results suggest that these immunopathological phenomena
might be due to immunosuppressive eﬀects of hydro-
quinone. In the present study, hydroquinone suppressed
most stages of innate immunity mediated by monocytes and
macrophages, and of adaptive immunity by lymphocytes,
as summarized in Figure 11. Our results suggest that the
initialactivationofmacrophagesbybacterialinfectionmight
be diminished by hydroquinone exposure. Additionally,
hydroquinone might inhibit the migration of monocytes
from the blood to infected areas and the aggregation of
these cells at infection sites, since it blocked upregulation
of integrins (CD18 and CD29) and their functional acti-
vation as assessed by homotypic aggregation of monocytic10 Mediators of Inﬂammation
cells. Finally, hydroquinone reduced the normal viability
of lymphocytes from bone marrow and spleen as well
as their LPS- and Con A-induced proliferation (Figure 9).
Previous reports have suggested that inhibition of IFN-γ
production from activated T cells and IL-12 production
from activated macrophages was blocked by hydroquinone
treatment and supported an inhibitory role in Th1-type
lymphocytes [30–32].
In conclusion, we report that hydroquinone nega-
tively regulates the functional activation of monocytes,
macrophages, and lymphocytes (summarized in Figure 11)
with respect to proinﬂammatory cytokine production, secre-
tion of cytotoxic molecules, phagocytic uptake, costimu-
latory molecule expression, monocytic cell-cell adhesion,
and lymphocyte proliferation. These eﬀects appear to be
mediated by reactions with thiol groups of L-cysteines in
targetproteins.Consideringthat(1)hydroquinoneisamajor
component of cigarette smoke and that (2) immunoprotec-
tion of chronic cigarette smokers against lung infections is
greatly reduced [29, 33], our data suggest that hydroquinone
and other benzene metabolites might play a role in various
immunotoxicological conditions.
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